POSTER: AML-554 A Phase III, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Azacitidine in Previously Untreated Patients With TP53-Mutant Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
AML,magrolimab,azacitidine,ENHANCE-2,anti-CD47,Trial-in-Progress
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要